VX-765 (Belnacasan)
Catalog No. A10984
VX-765 (Belnacasan)是一种新型的Caspase-1抑制剂,是一种控制两种细胞因子IL-1b和IL-18生成的酶。
- Arjun Thapa, .et al. Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cells, Leukemia, 2021, 23 February
- Prenitha Mercy Ignatius Arokia Doss, .et al. Male sex chromosomal complement exacerbates the pathogenicity of Th17 cells in a chronic model of central nervous system autoimmunity, Cell Rep, 2021, Mar 9;34(10):108833 PMID: 33691111
- Joseph Flores, .et al. Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging, Nat Commun, 2020, Sep 11;11(1):4571 PMID: 32917871
- Joseph Flores, .et al. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model, Nat Commun, 2018, 9: 3916 PMID: 30254377
- Mohamed F. Ali, .et al. Canonical Stimulation of the NLRP3 Inflammasome by Fungal Antigens Links Innate and Adaptive B-Lymphocyte Responses by Modulating IL-1β and IgM Production, Front Immunol, 2017, 8: 1504 PMID: 29170665
- García-Fernández A, .et al. Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles, J Control Release, 2017, Feb 28;248:60-70 PMID: 28069553
- Jiujiu Yu, .et al. Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy, Proc Natl Acad Sci U S A, 2014, 111(43): 15514-15519 PMID: 25313054
Catalog Num | A10984 |
---|---|
M. Wt | 509.0 |
Formula | C24H33ClN4O6 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 273404-37-8 |
Synonyms | VX765 |
SMILES | CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl |
VX-765 (Belnacasan)是一种新型的Caspase-1抑制剂,是一种控制两种细胞因子IL-1b和IL-18生成的酶。
Targets
Caspase-4 (Cell-free assay) | Caspase-1 (Cell-free assay) | |||
<0.6 nM(Ki) | 0.8 nM(Ki) |
In vitro (25°C) | DMSO | Warmed: 87 mg/mL (170.92 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 87 mg/mL (170.92 mM) | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.65 mL | 98.23 mL | 196.46 mL |
0.5 mM | 3.93 mL | 19.65 mL | 39.29 mL |
1 mM | 1.96 mL | 9.82 mL | 19.65 mL |
5 mM | 0.39 mL | 1.96 mL | 3.93 mL |
*The above data is based on the productmolecular weight 509.0 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.